Stem Cell Therapy Liver Cirrhosis: Evidence and Risks
MSC therapy for cirrhosis remains investigational: a pooled MELD improvement of about 1.22 points illustrates its modest, mainly short-term effects on MELD, Child-Pugh, platelets and albumin. These changes don't prove reversal of liver scarring, and treatment doesn't replace standard hepatology care. The important question isn't whether a blood test improves after treatment. It's whether patients…